DekaBank Deutsche Girozentrale
XBIT icon

DekaBank Deutsche Girozentrale’s XBiotech XBIT Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8,500
Closed -$110K – 1490
2021
Q3 		$110K Hold
8,500
– – ﹤0.01% 1292
2021
Q2 		$137K Hold
8,500
– – ﹤0.01% 1292
2021
Q1 		$141K Hold
8,500
– – ﹤0.01% 1244
2020
Q4 		$130K Hold
8,500
– – ﹤0.01% 1247
2020
Q3 		$157K Buy
+8,500
New +$147K ﹤0.01% 1078
2016
Q3 		– Sell
-18,000
Closed -$376K – 1030
2016
Q2 		$376K Buy
18,000
+4,000
+29% +$57.7K ﹤0.01% 736
2016
Q1 		$134K Buy
+14,000
New +$116K ﹤0.01% 909

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale's XBIT Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of XBiotech (XBIT) in Q4 2021, closing a stake of 8,500 shares — an estimated $110K sold.

DekaBank Deutsche Girozentrale first reported a position in XBIT in Q1 2016 and held it in 7 quarters. The position peaked at $376K in Q2 2016. 61 funds tracked by Wall St. Rank hold XBIT as of Q4 2021.

  • DekaBank Deutsche Girozentrale reported no remaining XBiotech position as of Q4 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 8,500 XBiotech shares in Q4 2021, an estimated $110K.
  • DekaBank Deutsche Girozentrale first reported a position in XBiotech in Q1 2016 and held it in 7 quarters.
  • DekaBank Deutsche Girozentrale's XBiotech position peaked at $376K in Q2 2016.
  • 61 funds tracked by Wall St. Rank held XBiotech as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.